{"title":"Co-Occurring Post Traumatic Stress Disorder and Opioid Dependence: A Role for Buprenorphine","authors":"I. Danovitch, S. Comer, M. Sullivan","doi":"10.2174/1874941000902010021","DOIUrl":null,"url":null,"abstract":"Post Traumatic Stress Disorder (PTSD) is highly prevalent among individuals addicted to opioids and complicates the course of illness and treatment response. Evidence-based treatments for patients with co-occurring opioid abuse and PTSD are lacking. Furthermore, little is known about the potential benefits of partial agonist therapy for these co-occurring conditions. We report the case of a patient with PTSD and opioid dependence, who experienced substantial symptomatic improvement with buprenorphine. We conclude that screening for PTSD in the opioid-abusing population is imperative, that buprenorphine may have important therapeutic benefits, and that future studies should examine the efficacy of partial-agonist opioids for concurrent PTSD and opioid dependence.","PeriodicalId":89289,"journal":{"name":"The open addiction journal","volume":"2 1","pages":"21-23"},"PeriodicalIF":0.0000,"publicationDate":"2009-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The open addiction journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874941000902010021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
Post Traumatic Stress Disorder (PTSD) is highly prevalent among individuals addicted to opioids and complicates the course of illness and treatment response. Evidence-based treatments for patients with co-occurring opioid abuse and PTSD are lacking. Furthermore, little is known about the potential benefits of partial agonist therapy for these co-occurring conditions. We report the case of a patient with PTSD and opioid dependence, who experienced substantial symptomatic improvement with buprenorphine. We conclude that screening for PTSD in the opioid-abusing population is imperative, that buprenorphine may have important therapeutic benefits, and that future studies should examine the efficacy of partial-agonist opioids for concurrent PTSD and opioid dependence.